COMPANY:

Gestalt Diagnostics

"Gestalt Diagnostics...and Pramana...announced a new integrated digital and AI-powered platform for laboratories, health systems, and academic medical centers. The platform offers Gestalt's embedded Mitotic Cell Counting algorithm and runs in-line on Pramana's spectral family of scanners."

"Gestalt Diagnostics...announce our latest release – an AI algorithm for use on one of the broadest trained environments for commercial or research use. The Mitotic Counting algorithm was trained on over 100,000 individual mitosis and across seven scanner models. The algorithm boasts an F1-Score of 0.74, which is tantamount to the best state-of-the-art methods."

"Cerebrum...announced a new capability and partnership with Gestalt Diagnostics from the 2023 NSH Convention to help pathologists increase their productivity and accuracy. Cerebrum's LABdivus^® now supports a bi-directional digital pathology integration with Gestalt's award winning digital platform, PathFlow^®."

"Gestalt Diagnostics is honored to have taken 1st place in both International challenges. Hundreds of groups participated in each challenge and Gestalt's algorithms achieved highest ranking...International challenges enable companies such as Gestalt to collaborate with colleagues on their development by competing on items such as theory, application, approach and finally being scored on what matters most, the accuracy of the algorithm when it is applied and scientifically reviewed."

"Gestalt Diagnostics Inc...and ARUP Laboratories, a national academic reference laboratory with hospital and health system clients in all 50 states, today announced that ARUP has selected Gestalt's award-winning PathFlow® digital platform as the solution to support its comprehensive vision for digital pathology."